This episode of "In the Arena" examines the emerging field of psychedelic medicine. Host Evan Baehr talks with Dr. Matthew Johnson, a key researcher from Johns Hopkins University, about how psilocybin and MDMA are being studied to treat depression, PTSD, and addiction. Their discussion covers the science of psychedelics, their potential benefits, and the obstacles to incorporating them into mainstream healthcare. We then visit Beond, an Ibogaine treatment center in Mexico, to see how psychedelic therapy helps patients battling severe addiction. The episode pushes viewers to rethink their views on psychedelics and consider their possible role in addressing mental health crises. By presenting both the research and real-world uses, we spotlight innovative approaches to one of society's most urgent problems.